Thanks Fulma
@Tardis
I am pretty certain that La Mancha's internal transfer is separate from the market action we have seen.
I don’t think it’s either of those. I think @theorist is right.
"Even with the inclusion of that single rogue trade at 138.75p"
Can you recall what size that trde was @taufour?
That's because there is one MM who is willing to buy them at the moment. He/she has put the smallest possible improvement on the RSP, while the others MMs, who don't want to compete, have no improvement at all on the RSP. So the tiny improvement is winning the trades.
"Loads of people put a buy share price on the order book and put loads of sell trades a few pence away from 140-142p area as well."
That would be market manipulation…….
"The SP is clearly being manipulated here - This is what you get with massive stock overhangs. Hope you are not feeling too trapped. Since 5th of April the action is non existent. Watching paint dry is far more interesting."
How is it being manipulated if there’s no action?
TR1 from 8th Feb.
Filtered. I don't mind a considered look at the downside risks to this stock but this is just shouty guessing
I didn't see the bit where they said a P3 trial would be starting this year?
Pure spaculation.
On time, on budget, construction 50%+ complete.
"Go on tell me, what is the future plan for the company? "
The concern is not that the company might not have a plan, but that they have a plan and it’s not working.
If you block out negative opinions and only listen to positive views you will be a very poor investor.
"Aether - Can you please stop posting that link, posting in this manner is abusive. Trivialising and making fun of mental health is not acceptable in todays society there is no place for this behaviour.."
I agree with Ghia on this
"Absolutely nothing stopping Synairgen saying something along the lines of “we are in advanced negotiations with a major pharma for a trial with commercial milestones” or “we are in advanced discussions for a global platform trial”. "
Unless they’re not
@Wigster77
Synairmilesgen lol
"This is very interesting and it does indicate we may be on a trial of sorts."
I honestly can’t see that it even hints at this. It’s just a bit of business as usual marketing.
"I don't think their strategy has changed. Mid to long term investment. Wait. Let the science and data accumulate until an inflection point gives them an exit on the back of some attractive commercial deal that satisfies their price target. "
I think that’s different from their original strategy, which (like for many of us) was to buy in advance of positive trial results and then sell at a mahoosive profit.
I would guess their subsequent strategy has been to look gloomily at the valuation on their books while having many meetings to discuss what to do with this lame duck investment, and hoping that Synairgen somehow find a way out of this mess.
There is no alternative